MDM4: What do we know about the association between its polymorphisms and cancer?
- 24 December 2022
- journal article
- review article
- Published by Springer Nature in Medical Oncology
- Vol. 40 (1) , 1-13
Abstract
MDM4 is an important p53-negative regulator, consequently, it is involved in cell proliferation, DNA repair, and apoptosis regulation. MDM4 overexpression and amplification are described to lead to cancer formation, metastasis, and poor disease prognosis. Several MDM4 SNPs are in non-coding regions, and some affect the MDM4 regulation by disrupting the micro RNA binding site in 3'UTR (untranslated region). Here, we gathered several association studies with different MDM4 SNPs and populations to understand the relationship between its SNPs and solid tumor risk. Many studies failed to replicate their results regarding different populations, cancer types, and risk genotypes, leading to conflicting conclusions. We suggested that distinct haplotype patterns in different populations might affect the association between MDM4 SNPs and cancer risk. Thus, we propose to investigate some linkage SNPs in specific haplotypes to provide informative MDM4 markers for association studies with cancer.Keywords
Funding Information
- Pronex-FA/CNPq (116/2018)
- CNPq (406187/2016-9)
This publication has 100 references indexed in Scilit:
- Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machineryGenes & Development, 2013
- Association of a Genetic Variation in a miR-191 Binding Site in MDM4 with Risk of Esophageal Squamous Cell CarcinomaPLOS ONE, 2013
- SIFT web server: predicting effects of amino acid substitutions on proteinsNucleic Acids Research, 2012
- Modifying effect of MDM4 variants on risk of HPV16‐associated squamous cell carcinoma of oropharynxCancer, 2011
- Polymorphisms of MDM4 and risk of squamous cell carcinoma of the head and neckPharmacogenetics and Genomics, 2011
- Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhingedGenes & Development, 2010
- Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogeneProceedings of the National Academy of Sciences, 2009
- Biogenesis of small RNAs in animalsNature Reviews Molecular Cell Biology, 2009
- Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer propertiesJournal of Molecular Medicine, 2008
- MDMX Promotes Proteasomal Turnover of p21 at G1 and Early S Phases Independently of, but in Cooperation with, MDM2Molecular and Cellular Biology, 2008